0001104659-17-060014.txt : 20170929 0001104659-17-060014.hdr.sgml : 20170929 20170929193449 ACCESSION NUMBER: 0001104659-17-060014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170927 FILED AS OF DATE: 20170929 DATE AS OF CHANGE: 20170929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talbot George Harrison CENTRAL INDEX KEY: 0001554194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 171112882 MAIL ADDRESS: STREET 1: C/O DURATA THERAPEUTICS, INC. STREET 2: 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 a4.xml 4 X0306 4 2017-09-27 0 0001641640 Nabriva Therapeutics plc NBRV 0001554194 Talbot George Harrison 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 1 0 0 0 Ordinary Shares 2017-09-27 4 M 0 1350 A 33140 D Stock Option 2017-09-27 4 M 0 1350 0 D 2017-09-27 Ordinary Shares 1350 0 D Dr. Talbot exercised his remaining stock options under the Company's Stock Option Plan 2007, which were set to expire on September 27, 2017. Dr. Talbot paid the exercise price in cash. The exercise price was .672 euros per share. These options were granted on various dates between 2009 and 2014 and are fully vested. /s/ Gary Sender, by power of attorney 2017-09-29